Clinical Trial Update: Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion [Phase 3]

View source ↗

Summary

A Phase 3 prospective controlled trial evaluating biliopancreatic diversion as a surgical treatment for Type 2 diabetes mellitus in patients with BMI 25-30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Type 2 Diabetes Mellitus, Bariatric Surgery | Phase 3 | Status: UNKNOWN